Skip to main content
Caplight Logo









Helix

Helix

Private
San Mateo, CaliforniaHealthcare & Life Scienceshttps://www.helix.com/

Last Round

Series C

Jun 3, 2021

Total Funding Raised

$383.4M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Helix is a genomics and data analytics company that provides actionable genetic insights and conducts large-scale genetic analysis to enhance patient care and public health decision-making.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Drug Discovery, Healthcare Analytics

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

population genomicsprecision medicinegenomic sequencingclinico-genomic databasedirect-to-consumer genetic testingDTC genetic testingdrug discoverypolygenic risk scoringclinical genomic integrationdata as a serviceDaaSgenomic data platformbiobankgenomic healthAI-ready datasets

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Helix Comparables

Compare Helix with similar companies based on industry and business-model similarity.

Helix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Tempus
78%
SOPHiA GENETICS
76%
DNAnexus
76%

Helix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJun 3, 2021
GrantJul 31, 2020
Series BMar 1, 2018
Series AAug 18, 2015

Key People

Founding team and executive leadership

James Lu

CEO, Co-Founder, Board Member

Founding Team

Jim Chou

CTO

Executive Team

Sarah Bobulsky

CFO COO

Executive Team

Helix Investors

Notable investors and investment history

Helix investors
InvestorRounds
TemasekSeries B, Series C
NIH RADxGrant
DFJ GrowthSeries B, Series C
Warburg PincusSeries B, Series A, Series C
VenrockSeries B
Kleiner PerkinsSeries B, Series C
Sutter Hill VenturesSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 7, 2026

    Clinical laboratory has achieved CAP accreditation.

  • May 7, 2026

    Clinical laboratory has received CLIA certification.

Helix Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Helix Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Helix's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Mateo, California
Employee Range599
Year Founded2015
Last FundingJun 3, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.